Navigation Links
Retrospective analysis of linagliptin data in sub-populations with type 2 diabetes presented at AACE 22nd Annual Scientific & Clinical Congress
Date:5/6/2013

vs. 16.3% in the placebo arm

Linagliptin, which is marketed as Tradjenta® (linagliptin) tablets in the U.S., is a once-daily 5mg tablet used along with diet and exercise to improve glycemic control in adults with type 2 diabetes.  Linagliptin should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis (increased ketones in the blood or urine).  Linagliptin is a DPP-4 inhibitor that does not require dose adjustments, regardless of declining renal function or hepatic impairment.

What are TRADJENTA (linagliptin) tablets?
TRADJENTA is a prescription medicine that is used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.

TRADJENTA is not for people with type 1 diabetes or for people with diabetic ketoacidosis (increased ketones in the blood or urine).

Important Safety Information

Who should not take TRADJENTA?
Do not take TRADJENTA if you are allergic to linagliptin or any of the ingredients in TRADJENTA. Symptoms of a serious allergic reaction to TRADJENTA are rash, raised red patches on your skin (hives), swelling of your face, lips, and throat that may cause difficulty breathing or swallowing. If you have any symptoms of a serious allergic reaction, stop taking TRADJENTA and call your doctor right away.

What should I tell my doctor before taking TRADJENTA?
Tell your doctor if you take other medicines that can lower your blood sugar, such as a sulfonylurea or insulin.

TRADJENTA may cause serious side effects, including low blood sugar (hypoglycemia). If you take TRADJENTA with another medicine that can cause low blood sugar, such as sulfonylurea or insulin, your risk of getting low blood sugar is higher. The dose of your sulfonylurea or insulin may need to be lowered while you take TRADJENTA.

Signs and symptoms of low blood sugar may include headache, drowsiness, weakness, dizziness, confusion, irritab
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Organogenesis to Present Large Retrospective Comparative Effectiveness Analysis and Health Economic Data in Chronic Wound Healing at The Symposium on Advanced Wound Care and Wound Healing Society Meeting
2. Valeritas Announces The Publication Of A Retrospective Analysis Of Patient-Reported Data On The V-Go In The Current Issue Of Endocrine Practice
3. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
4. New Interim Analysis From Observational Study Suggests That Delivery Of Insulin Via Valeritas V-Go Shows Promise In Improving Glycemic Control For Patients With Type 2 Diabetes
5. Pharmacy Automation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
6. Immunomic Therapeutics Announces Interim Data Analysis of Phase I Study to Treat Japanese Red Cedar Allergy
7. Small Animal Imaging (In Vivo) Market - By systems and reagents - Competitive Analysis & Global Forecasts to 2017
8. 2013 BRIC Medical Devices Market & CIVETS Medical Equipment Industry Analysis
9. 2013 Cancer Diagnostics Market Analysis: Cancer Testing Industry Growing Rapidly
10. Antibody Technologies and Attrition Rates - An Industry Analysis 2013
11. Medical Equipment Monthly Deals Analysis: February 2013 - M&A and Investment Trends
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... PARK, N.C. , March 31, 2015  Dr. ... will be attending the World Orphan Drug Congress in April ... regulatory approval process and orphan drugs below: ... (DTAB) has recommended to the Ministry of Health that if ... country, marketing authorization can be obtained in India ...
(Date:3/31/2015)...  On May 2, 2015 global experts on ... Santa Monica, CA at the 5th ... Pleural Mesothelioma (MPM), a rare form of cancer ... affects the lining of the chest– the pleura. ... Pacific Mesothelioma Center (PMC). ...
(Date:3/31/2015)... BC , March 31, 2015 /CNW/ - T-Bird Pharma ... focused on developing premium quality medical marijuana products and ... Marihuana for Medical Purposes Regulations ( Canada ... received notice from The Corporation of the District of ... approval of the Company,s premises which now allows for ...
Breaking Medicine Technology:Max Neeman to Discuss India's Orphan Drug Regulations at WOD 2015 2Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 2Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 3Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 4T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3
... Bionovo, Inc.,(Nasdaq: BNVI ) announced today that its ... Phase 2 clinical testing after the,successful completion of a ... clinical trial was conducted to identify the maximum,tolerated dose ... of the,company,s novel, oral, anticancer treatment. A total of ...
... MedImmune today announced,that it has initiated a Phase ... healthy children one month to 12 months of age ... is,the most common respiratory infection in infants and can ... is a serious respiratory disease that can have significant ...
Cached Medicine Technology:Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 2Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 3Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer 4MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine 2
(Date:3/31/2015)... (PRWEB) March 31, 2015 The American ... events. The schedule for April will include interesting workshops, ... New Student Orientation, 9-11 a.m. April 6, ACTCM welcomes ... Room D at the Pioneer Square Campus located at ... Aid, 12:30-1:30 p.m. April 14, Students will be updated ...
(Date:3/31/2015)... Many people, including the ones with ... and cycling are only for able-bodied participants. , ... Institute aims to change that thinking. , The ... an Adaptive Sports Expo on Saturday, April 11 (10 ... in Hollywood. , The event will showcase a ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 On March 26, ... Go Down the Silicone Slope?” provides a look into the ... filler , and laser treatments . The article suggests ... reality TV stars such as Kim Kardashian and Kylie Jenner ... media are increasingly seen as significant influences on the self-esteem ...
(Date:3/31/2015)... NJ (PRWEB) March 31, 2015 Dr. Russell ... for Advanced Reconstruction. He was recently quoted in an ... caused by lymphatic issues, causing fluid retention and tissue swelling. ... procedure to relieve and / or improve lymphedema symptoms. ... improve or alleviate the symptoms of lymphedema. The goal ...
(Date:3/31/2015)... March 31, 2015 Beckman Coulter is sponsoring ... USP 787: “Subvisible Particulate Matter in Therapeutic Protein Injections”,” an ... new demands in counting particles in liquids, with a focus ... webinar is free to attend and will be broadcast live ... posted a new test for protein-based materials, known as ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces April Event Schedule 2Health News:Memorial Healthcare System's Adaptive Sports Expo Encourages Physically Challenged To Go Beyond Perceived Limitations 2Health News:Cosmetic Surgery: Does Social Media Pressure Young Girls to Get Botox and Fillers? 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 3Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 4Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 2Health News:Beckman Coulter Webinar Series Presents Insight into New Demands in Counting Particles in Liquids 3
... ban on junk food in school canteens following a report ... its report// has shown concern about the increasing number of ... out by DDRC in 38 schools showed that one in ... food rampant in the school canteens contributed towards this cause. ...
... the source or inspiration of most new drugs created in the ... work in the natural// products branch of the National Cancer ... all new drugs approved from January 1981 through June 2006 for ... wide range of conditions. ,Only thirty percent of the ...
... the high during weekends. This is attributed to the quality ... patients. This study was conducted by William J. Kostis and ... New Jersey in New Brunswick. ,Kostis ... between the years 1987 and 2002. These were patients suffering ...
... Former Chhattisgarh's chief minister Ajit Jogi was hospitalized here ... arrested in connection// with the murder of Nationalist Congress ... was brought to Raipur at 4.10 a.m. Monday and ... chest pain," Jogi's family sources told IANS. ...
... A new study that was published in Britain indicates that the ... still more than the desired// level. Health experts opine that cardiac ... salt intake. ,According to the report, there is a ... last measured in 2001. Men have cut down their salt intake ...
... hormone that is important in the control of blood pressure ... way to prevent or treat the deadly cancer, according to ... scientists said that in mice treated with the hormone, angiotensin-(1-7), ... not receive the treatment, the tumor size more than doubled. ...
Cached Medicine News:Health News:Drug for Blood Pressure also Treats Lung Cancer 2
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
Intermittent catheter - Ready-to-Use Sterile, Enclosed System...
... The VerifyNow (Ultegra) System is ... which measures platelet induced aggregation as ... system consists of an instrument, a ... assay device contains reagents based on ...
... The Model 700 Whole Blood/Optical Lumi-Aggregometer available ... This new Aggregometer measures platelet function on ... blood or optical density in plasma with ... method. The Model 700 Aggregometer also has ...
Medicine Products: